[Congressional Record Volume 171, Number 131 (Wednesday, July 30, 2025)]
[Senate]
[Page S4921]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3138. Mr. GALLEGO submitted an amendment intended to be proposed 
by him to the bill S. 2296, to authorize appropriations for fiscal year 
2026 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

        At the end of subtitle F of title X, add the following:

     SEC. 1067. RESEARCH ON INNOVATIVE THERAPIES FOR VETERANS.

       (a) In General.--The Secretary of Veterans Affairs shall 
     conduct research on innovative therapies, including MDMA, 
     ibogaine, ketamine, and psilocybin, to treat anxiety, bipolar 
     disorder, chronic pain, depression, Parkinson's disease, 
     post-traumatic stress disorder, and substance use disorder 
     among veterans.
       (b) Report.--Not later than one year after the date of the 
     enactment of this Act, the Secretary shall submit to Congress 
     a report containing any findings or recommendations of the 
     Secretary on improving the delivery of innovative therapies 
     to veterans.
                                 ______